Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Post by NgamiaSwedeon Jul 02, 2014 5:19pm

273 Views

Post# 22711017

Target

Is there anyone that know the target in the Cancercell they aim for? Is i down to Chromosome? or Telomeres?
More and more points to Telomeres as the start off cancers, then it should bee the DNA in the Telomeres that is the target. In a cancercell Telomeres is the tail off a Chromosome and the tail is what keeps the cancer going when cell are divided to new ones.
Sure there must be any who knows?
Thanks!

Bullboard Posts

Advancing flagship Ishkõday Gold Project in Ontario